Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03750786
Title A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer (AGENT)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Isofol Medical AB
Indications

colorectal adenocarcinoma

Therapies

Arfolitixorin + Bevacizumab + Fluorouracil + Oxaliplatin

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.